Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial

NCT06263816 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

290

Enrollment

OTHER

Sponsor class

Conditions

Asymptomatic Cirrhosis
Clinically Significant Portal Hypertension

Interventions

DRUG: Experimental group: Patients will be treated with carvedilol.
OTHER: Control group: Patients will receive a placebo.

Sponsor

University Hospital, Tours

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]